HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.

AuthorsChikae Nakashima, Hiroshi Keino, Takayo Watanabe, Wakako Taki, Annabelle A Okada
JournalJapanese journal of ophthalmology (Jpn J Ophthalmol) Vol. 55 Issue 1 Pg. 80-1 (Jan 2011) ISSN: 1613-2246 [Electronic] Japan
PMID21331703 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antihypertensive Agents
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antihypertensive Agents (administration & dosage)
  • Bevacizumab
  • Carcinoma, Small Cell (drug therapy, secondary)
  • Glaucoma, Neovascular (drug therapy, pathology)
  • Humans
  • Intraocular Pressure (drug effects)
  • Intravitreal Injections
  • Iris Neoplasms (drug therapy, secondary)
  • Lung Neoplasms (drug therapy, pathology)
  • Male
  • Middle Aged
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: